Products for Research Use Only
RegisterLogin

Mupadolimab

CAT: 0804-HY-P99181-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99181-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Mupadolimab (CPI-006) is an IgG1κ humanized FcγR binding-deficient anti-CD73 monoclonal antibody (mAb) that activates CD73POS B cells[1].
CAS Number
2451856-97-4
Product Name Alternative
CPI-006
UNSPSC
12352203
Target
CD73
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/mupadolimab.html
Purity
99.43
Solubility
10 mM in DMSO
Smiles
[Mupadolimab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Miller R A, et al. Clinical results with a B cell activating anti-CD73 antibody for the immunotherapy of Covid-19. medRxiv, 2021.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T76735-01Mupadolimab
GTR18338479-01Mupadolimab Antibody
HB209046-01Research Grade Mupadolimab
E55B0827Mupadolimab (Reference antibody)
MBS3030497-01Mupadolimab Biosimilar - Research Grade
ABS-244-1mgMupadolimab Biosimilar, Research Grade
GTR18780725-01(Mupadolimab) Biosimilar Reference Antibody
A2388-1mgMupadolimab (Anti-NT5E / CD73)
A138466Mupadolimab Biosimilar (Monoclonal, IgG1)
048281-01CD73, Mupadolimab Biosimilar (NT5E)

Popular Products